An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.
作者信息
Stenning S P, Freedman L S, Bleehen N M
出版信息
Br J Cancer. 1987 Jul;56(1):89-90. doi: 10.1038/bjc.1987.161.
Abstract
摘要
相似文献
1
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.亚硝基脲类药物用于原发性高级别恶性胶质瘤随机研究的已发表结果概述。
Br J Cancer. 1987 Jul;56(1):89-90. doi: 10.1038/bjc.1987.161.
2
Chemotherapy for high-grade glioma.
Neuroepidemiology. 2003 Nov-Dec;22(6):366. doi: 10.1159/000072928.
3
Clinical studies in malignant gliomas and their treatment with the nitrosoureas.恶性胶质瘤的临床研究及其亚硝基脲类药物治疗
Cancer Treat Rep. 1976 Jun;60(6):713-6.
4
Nitrosoureas in central nervous system tumors.
Cancer Chemother Rep 3. 1973 May;4(3):21-6.
5
[Malignant gliomas: current status and therapeutic prospectives].
G Ital Chemioter. 1985 Jan-Apr;32(1):93-8.
6
[Chemotherapy of experimental glioma with nitrosoureas--comparison of water soluble ACNU and lipid soluble me-CCNU (author's transl)].
No To Shinkei. 1977 Aug;29(8):891-8.
7
Alternative chemotherapeutic agents: nitrosoureas, cisplatin, irinotecan.替代化疗药物：亚硝脲类、顺铂、伊立替康。
Neurosurg Clin N Am. 2012 Apr;23(2):297-306, ix. doi: 10.1016/j.nec.2012.01.005. Epub 2012 Feb 18.
8
[Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
Neurol Med Chir (Tokyo). 1981 Oct;21(10):1017-23. doi: 10.2176/nmc.21.1017.
9
Nitrosourea chemotherapy for primary malignant gliomas.原发性恶性胶质瘤的亚硝基脲化疗
Cancer Treat Rep. 1976 Jun;60(6):719-24.
10
Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.单用环己亚硝脲以及环己亚硝脲联合硫酸长春新碱和盐酸丙卡巴肼治疗恶性胶质瘤。
Trans Am Neurol Assoc. 1976;101:217-20.
引用本文的文献
1
Glioblastoma Cellular Origin and the Firework Pattern of Cancer Genesis from the Subventricular Zone.胶质母细胞瘤的细胞起源及源自脑室下区的癌症发生的烟花模式
J Korean Neurosurg Soc. 2020 Jan;63(1):26-33. doi: 10.3340/jkns.2019.0129. Epub 2019 Oct 8.
2
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma.对复发性胶质母细胞瘤中与卡莫司汀/贝伐珠单抗反应相关因素的综合分析。
Clin Transl Oncol. 2019 Oct;21(10):1364-1373. doi: 10.1007/s12094-019-02066-2. Epub 2019 Feb 23.
3
Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data.同步和辅助替莫唑胺的调强放疗用于间变性胶质瘤：印度单中心数据
Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):495-501. doi: 10.4103/ijmpo.ijmpo_200_16.
4
Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.对曾使用贝伐单抗但治疗失败的复发性胶质母细胞瘤患者使用卡莫司汀或洛莫司汀联合贝伐单抗的回顾性研究。
Neuro Oncol. 2014 Nov;16(11):1523-9. doi: 10.1093/neuonc/nou118. Epub 2014 Jun 23.
5
Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.替莫唑胺（TMZ）与1,3-双（2-氯乙基）-1-亚硝基脲（BCNU）在新诊断的多形性胶质母细胞瘤（GBM）患者中的对比分析。
J Neurooncol. 2009 Jan;91(2):221-5. doi: 10.1007/s11060-008-9702-6. Epub 2008 Sep 24.
6
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).一项针对新诊断的幕上胶质母细胞瘤成年患者的聚肌胞苷酸-聚左旋赖氨酸-羧甲基纤维素（poly-ICLC）联合放疗的II期临床试验：北美脑肿瘤联盟（NABTC01-05）
J Neurooncol. 2009 Jan;91(2):175-82. doi: 10.1007/s11060-008-9693-3. Epub 2008 Sep 17.
7
Chemotherapeutic options for primary brain tumors.原发性脑肿瘤的化疗选择
Curr Treat Options Oncol. 2006 Nov;7(6):467-78. doi: 10.1007/s11864-006-0022-9.
8
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.卡莫司汀联合伊立替康治疗成人恶性胶质瘤的2期试验。
Neuro Oncol. 2004 Apr;6(2):134-44. doi: 10.1215/s1152851703000413.
9
Radiation sterilisation of cultured human brain tumour cells for clinical immune tumour therapy.
Br J Cancer. 2004 Jan 12;90(1):48-54. doi: 10.1038/sj.bjc.6601467.
10
Chemotherapy for high-grade glioma.高级别胶质瘤的化疗
Cochrane Database Syst Rev. 2002;2002(4):CD003913. doi: 10.1002/14651858.CD003913.
本文引用的文献
1
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.术后放疗与亚硝基脲类药物治疗恶性胶质瘤的随机对照比较。
N Engl J Med. 1980 Dec 4;303(23):1323-9. doi: 10.1056/NEJM198012043032303.
2
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.术后放疗与术后放疗联合化疗在恶性胶质瘤多学科管理中的比较。放射治疗肿瘤学组与东部肿瘤协作组联合研究。
Cancer. 1983 Sep 15;52(6):997-1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2.
3
Adjuvant nitrosourea therapy for glioblastoma.
Arch Neurol. 1976 Nov;33(11):745-50. doi: 10.1001/archneur.1976.00500110013003.
4
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.卡氮芥和/或放疗治疗间变性胶质瘤的评估。一项合作临床试验。
J Neurosurg. 1978 Sep;49(3):333-43. doi: 10.3171/jns.1978.49.3.0333.
5
A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma.脑胶质瘤单纯放疗与放疗联合洛莫司汀的比较。
Clin Oncol. 1978 Mar;4(1):71-6.
Zotero 插件